PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Organ Transplantation 11,384 Disease Drug Alemtuzumab (Campath)- FDA 32 1 0.00 -0.98 0.03 0.62
Arthritis 128,324 Disease Drug Alemtuzumab (Campath)- FDA 32 1 0.00 -0.98 0.03 0.56
Anemia 81,663 Disease Drug Alemtuzumab (Campath)- FDA 32 1 0.00 -0.98 0.03 0.57
Respiratory Tract Infections 9,721 Disease Drug Alemtuzumab (Campath)- FDA 32 1 0.00 -0.98 0.03 0.62
Rheumatoid Arthritis 78,952 Disease Drug Alemtuzumab (Campath)- FDA 32 1 0.00 -0.98 0.03 0.57
Cholesterol 182,390 Disease Drug Kaempferitrin 32 1 0.00 -0.98 0.03 0.55
Hepatitis 163,842 Disease Drug Alemtuzumab (Campath)- FDA 32 1 0.00 -0.98 0.03 0.55
Hepatitis 163,842 Disease Target Maleylacetoacetate Isomerase 32 1 0.00 -0.98 0.03 0.55
Leukemias 14,152 Disease Drug Alemtuzumab (Campath)- FDA 32 1 0.00 -0.98 0.03 0.61
Analgesia 44,857 Disease Target Sodium Channel Nav1.8 31 1 0.00 -0.98 0.03 0.58
Platelet Aggregation 25,460 Disease Target Vascular Cell Adhesion Protein 1 31 1 0.00 -0.98 0.03 0.60
Sedimentation Rate 11,455 Disease Target Low-Density Lipoprotein Receptor-Related Protein 2 31 1 0.00 -0.98 0.03 0.62
Obesity 138,233 Disease Target Vascular Cell Adhesion Protein 1 31 1 0.00 -0.98 0.03 0.56
Hearing Loss 30,622 Disease Target Low-Density Lipoprotein Receptor-Related Protein 2 31 1 0.00 -0.98 0.03 0.59
Osteoarthritis 36,287 Disease Target Low-Density Lipoprotein Receptor-Related Protein 2 31 1 0.00 -0.98 0.03 0.59
Glaucoma 41,465 Disease Target Low-Density Lipoprotein Receptor-Related Protein 2 31 1 0.00 -0.98 0.03 0.58
Stroke 146,992 Disease Target Vascular Cell Adhesion Protein 1 31 1 0.00 -0.98 0.03 0.56
Diabetic Nephropathy 12,496 Disease Target Vascular Cell Adhesion Protein 1 31 1 0.00 -0.98 0.03 0.61
Meningitis 41,685 Disease Drug Amphotericin B (Fungizone)- FDA 30 1 0.00 -0.98 0.03 0.59
Seizure 44,685 Disease Target Collapsin Response Mediator Protein-1 30 1 0.00 -0.98 0.03 0.58
Diabetes 332,602 Disease Drug Acamprosate Calcium (Campral)- FDA 30 1 0.00 -0.98 0.03 0.54
Chills 3,046 Disease Drug Amphotericin B (Fungizone)- FDA 30 1 0.00 -0.98 0.03 0.65
Hearing Loss 30,622 Disease Target Collapsin Response Mediator Protein-1 30 1 0.00 -0.98 0.03 0.59
Depression 220,092 Disease Target Collapsin Response Mediator Protein-1 30 1 0.00 -0.98 0.03 0.55
Cancer 1,053,491 Disease Drug Amphotericin B (Fungizone)- FDA 30 1 0.00 -0.98 0.03 0.52
Brain Injury 34,874 Disease Target Collapsin Response Mediator Protein-1 30 1 0.00 -0.98 0.03 0.59
Prostate Cancer 71,064 Disease Target DNA-damage-inducible transcript 3 30 1 0.00 -0.98 0.03 0.57
Tuberculosis 146,217 Disease Drug Azathioprine (Imuran)- FDA 30 1 0.00 -0.98 0.03 0.56
Tuberculosis 146,217 Disease Drug Amphotericin B (Fungizone)- FDA 30 1 0.00 -0.98 0.03 0.56
Hyperglycemia 28,168 Disease Target DNA-damage-inducible transcript 3 30 1 0.00 -0.98 0.03 0.59
Diarrhea 51,986 Disease Target DNA-damage-inducible transcript 3 30 1 0.00 -0.98 0.03 0.58
Infection 766,637 Disease Drug Azathioprine (Imuran)- FDA 30 1 0.00 -0.98 0.03 0.53
Pneumonia 81,521 Disease Drug Amphotericin B (Fungizone)- FDA 30 1 0.00 -0.98 0.03 0.57
Headache 50,687 Disease Drug Amphotericin B (Fungizone)- FDA 30 1 0.00 -0.98 0.03 0.58
Dementia 66,782 Disease Target DNA-damage-inducible transcript 3 30 1 0.00 -0.98 0.03 0.57
Thrombocytopenia 35,805 Disease Drug Alimta (Pemetrexed)- FDA 28 1 0.00 -0.98 0.04 0.59
Acne 11,364 Disease Drug Alimta (Pemetrexed)- FDA 28 1 0.00 -0.98 0.04 0.62
Depression 220,092 Disease Drug Atorvastatin Calcium (Lipitor)- FDA 28 1 0.00 -0.98 0.04 0.55
Cancer 1,053,491 Disease Drug Atorvastatin Calcium (Lipitor)- FDA 28 1 0.00 -0.98 0.04 0.52
Cancer 1,053,491 Disease Drug Amlodipine Besylate (Norvasc)- FDA 28 1 0.00 -0.98 0.04 0.52
Cancer 1,053,491 Disease Target Squalene Monooxygenase 28 1 0.00 -0.98 0.04 0.52
Arrhythmia 29,330 Disease Drug Amlodipine Besylate (Norvasc)- FDA 28 1 0.00 -0.98 0.04 0.59
Ovarian Cancer 33,996 Disease Drug Alimta (Pemetrexed)- FDA 28 1 0.00 -0.98 0.04 0.59
Diarrhea 51,986 Disease Drug Amlodipine Besylate (Norvasc)- FDA 28 1 0.00 -0.98 0.04 0.58
Stroke 146,992 Disease Drug Atorvastatin Calcium (Lipitor)- FDA 28 1 0.00 -0.98 0.04 0.56
Lung Carcinoma 13,423 Disease Drug Alimta (Pemetrexed)- FDA 28 1 0.00 -0.98 0.04 0.61
Renal Failure 73,993 Disease Drug Alimta (Pemetrexed)- FDA 28 1 0.00 -0.98 0.04 0.57
Arthritis 128,324 Disease Drug Amlodipine Besylate (Norvasc)- FDA 28 1 0.00 -0.98 0.04 0.56
Anemia 81,663 Disease Drug Alimta (Pemetrexed)- FDA 28 1 0.00 -0.98 0.04 0.57
Benign Prostatic Hyperplasia 10,026 Disease Drug Amlodipine Besylate (Norvasc)- FDA 28 1 0.00 -0.98 0.04 0.62
Rheumatoid Arthritis 78,952 Disease Drug Amlodipine Besylate (Norvasc)- FDA 28 1 0.00 -0.98 0.04 0.57
Seborrhea 430 Disease Target Epigen 27 1 0.01 -0.98 0.04 0.71
Colon Cancer 30,064 Disease Target Epigen 27 1 0.00 -0.98 0.04 0.59
Skin Disease 6,955 Disease Target Epigen 27 1 0.00 -0.98 0.04 0.63
Seizure 44,685 Disease Target Epigen 27 1 0.00 -0.98 0.04 0.59
Cocaine Dependence 1,358 Disease Drug Antabuse (Disulfiram)- FDA 27 1 0.01 -0.98 0.04 0.68
Psychiatric Disorder 6,440 Disease Drug Antabuse (Disulfiram)- FDA 27 1 0.00 -0.98 0.04 0.63
Sedimentation Rate 11,455 Disease Target Apo-SAA 27 1 0.00 -0.98 0.04 0.62
Drug Abuse 13,496 Disease Target Epigen 27 1 0.00 -0.98 0.04 0.61
Carcinoma 433,099 Disease Target DAPK2 27 1 0.00 -0.98 0.04 0.54
Osteoarthritis 36,287 Disease Disease Arthritis Juvenile 27 1 0.00 -0.98 0.04 0.59
Cancer 1,053,491 Disease Target Apo-SAA 27 1 0.00 -0.98 0.04 0.52
Cancer 1,053,491 Disease Target Exodus-2 27 1 0.00 -0.98 0.04 0.52
Nausea 42,627 Disease Drug Antabuse (Disulfiram)- FDA 27 1 0.00 -0.98 0.04 0.59
Fibromyalgia 6,837 Disease Disease Arthritis Juvenile 27 1 0.00 -0.98 0.04 0.63
Anxiety 113,510 Disease Drug Antabuse (Disulfiram)- FDA 27 1 0.00 -0.98 0.04 0.57
Anxiety 113,510 Disease Drug Alosetron Hydrochloride (Lotronex)- FDA 27 1 0.00 -0.98 0.04 0.57
Hypertriglyceridemia 7,877 Disease Target Apo-SAA 27 1 0.00 -0.98 0.04 0.63
Tuberculosis 146,217 Disease Disease Arthritis Juvenile 27 1 0.00 -0.98 0.04 0.56
Infection 766,637 Disease Drug Antabuse (Disulfiram)- FDA 27 1 0.00 -0.98 0.04 0.53
Infection 766,637 Disease Target Apo-SAA 27 1 0.00 -0.98 0.04 0.53
Schizophrenia 77,034 Disease Drug Antabuse (Disulfiram)- FDA 27 1 0.00 -0.98 0.04 0.57
Stroke 146,992 Disease Target Exodus-2 27 1 0.00 -0.98 0.04 0.56
Osteoporosis 46,215 Disease Disease Arthritis Juvenile 27 1 0.00 -0.98 0.04 0.58
Glomerulonephritis 23,459 Disease Target Apo-SAA 27 1 0.00 -0.98 0.04 0.60
Shock 134,031 Disease Target Apo-SAA 27 1 0.00 -0.98 0.04 0.56
Joint Pain 4,215 Disease Disease Arthritis Juvenile 27 1 0.00 -0.98 0.04 0.64
Celiac Disease 8,026 Disease Disease Arthritis Juvenile 27 1 0.00 -0.98 0.04 0.63
Sarcoidosis 19,176 Disease Disease Arthritis Juvenile 27 1 0.00 -0.98 0.04 0.61
Platelet Aggregation 25,460 Disease Drug Alprostadil (Prostin VR Pediatric)- FDA 26 1 0.00 -0.98 0.04 0.60
Skin Disease 6,955 Disease Target Eotaxin-3/CCL26 26 1 0.00 -0.98 0.04 0.63
Diabetes 332,602 Disease Target CEBP alpha 26 1 0.00 -0.98 0.04 0.54
Diabetes 332,602 Disease Drug Alprostadil (Prostin VR Pediatric)- FDA 26 1 0.00 -0.98 0.04 0.54
Thromboembolism 23,698 Disease Drug Alprostadil (Prostin VR Pediatric)- FDA 26 1 0.00 -0.98 0.04 0.60
Obesity 138,233 Disease Drug Alprostadil (Prostin VR Pediatric)- FDA 26 1 0.00 -0.98 0.04 0.56
Carcinoma 433,099 Disease Target AURKC 26 1 0.00 -0.98 0.04 0.54
Cervical Cancer 28,286 Disease Target AURKC 26 1 0.00 -0.98 0.04 0.60
Hemorrhage 100,979 Disease Drug Alprostadil (Prostin VR Pediatric)- FDA 26 1 0.00 -0.98 0.04 0.57
Fracture 111,575 Disease Target CEBP alpha 26 1 0.00 -0.98 0.04 0.57
Prostate Cancer 71,064 Disease Drug Alprostadil (Prostin VR Pediatric)- FDA 26 1 0.00 -0.98 0.04 0.58
Inflammatory Bowel Disease 24,375 Disease Target Eotaxin-3/CCL26 26 1 0.00 -0.98 0.04 0.60
Infection 766,637 Disease Target Eotaxin-3/CCL26 26 1 0.00 -0.98 0.04 0.53
Infection 766,637 Disease Target CEBP alpha 26 1 0.00 -0.98 0.04 0.53
Kidney Diseases 4,651 Disease Target BD4 26 1 0.00 -0.98 0.04 0.64
Hepatitis B 57,815 Disease Disease Transplant Bone Marrow 26 1 0.00 -0.98 0.04 0.58
Stroke 146,992 Disease Drug Alprostadil (Prostin VR Pediatric)- FDA 26 1 0.00 -0.98 0.04 0.56
Dyspnea 24,781 Disease Drug Alprostadil (Prostin VR Pediatric)- FDA 26 1 0.00 -0.98 0.04 0.60
Aspergillosis 9,759 Disease Disease Transplant Bone Marrow 26 1 0.00 -0.98 0.04 0.62
Gastroesophageal Reflux Disease 7,437 Disease Target AURKC 26 1 0.00 -0.98 0.04 0.63
Osteoporosis 46,215 Disease Drug Alprostadil (Prostin VR Pediatric)- FDA 26 1 0.00 -0.98 0.04 0.59